Jade Biosciences, Inc. Earnings Per Share, Basic and Diluted
Jade Biosciences, Inc. (JBIO) reported Earnings Per Share, Basic and Diluted of -$1.87 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-30
- Jade Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.33.
- Jade Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.26.
- Jade Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$23.80.
- Jade Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$15.08.
- Jade Biosciences, Inc. earnings per share, basic and diluted for fiscal 2021 was -$1.87.
- Jade Biosciences, Inc. earnings per share, basic and diluted for fiscal 2020 was -$40.31.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$0.33 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$0.59 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$1.24 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$1.87 10-K · filed 2022-03-30 |
| 2021-09-30 | -$0.26 10-Q · filed 2021-11-15 | -$0.99 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$1.80 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$23.80 10-Q · filed 2021-08-16 | -$35.29 10-Q · filed 2021-08-16 | ||
| 2020-12-31 | -$15.08 derived: net income ÷ weighted average shares · filed 2022-03-30 | -$25.21 derived: net income ÷ weighted average shares · filed 2022-03-30 | -$34.34 derived: net income ÷ weighted average shares · filed 2022-03-30 | -$40.31 10-K · filed 2022-03-30 |
| 2020-09-30 | -$10.13 10-Q · filed 2021-11-15 | -$19.25 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$25.20 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$9.12 10-Q · filed 2021-08-16 | -$15.07 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |